The relation between neutrophil/lymphocyte and platelet/lymphocyte ratios with mortality and limb amputation after acute limb ischaemia

Abstract

Objective

Acute limb ischaemia is still considered a significant event, with considerable early- and long-term amputation and mortality risk. Our study aims to investigate the predictive role of pre-operative neutrophil/lymphocyte and platelet/lymphocyte ratios in terms of mortality and amputation risk in patients with acute limb ischaemia.

Methods

Pre-operative blood samples of all patients admitted with acute limb ischaemia were used to calculate neutrophil/lymphocyte and platelet/lymphocyte ratios. Population was subdivided into quartiles by platelet/lymphocyte ratio and neutrophil/lymphocyte ratio values, and Kaplan-Meier life tables were obtained for overall survival and limb salvage. The optimal neutrophil/lymphocyte ratio and platelet/lymphocyte ratio cut-offs were obtained from receiver operating characteristic curves with all-cause mortality and all kinds of amputation. Stepwise multivariate analysis was performed in order to identify independent risk and protective factors for mortality and amputations.

Results

A total of 168 patients were included in the analysis. Receiver operating characteristic curves identified cut-off values for neutrophil/lymphocyte ratio and platelet/lymphocyte ratio: neutrophil/lymphocyte ratio ≥5.57 for mortality; neutrophil/lymphocyte ratio ≥6.66 and platelet/lymphocyte ratio ≥269.9 for all amputations. Kaplan-Meier analysis revealed that survival rate in group neutrophil/lymphocyte ratio <5.57 was 83.4%, 78.9%, 73.7%, and 59.8%, respectively, at 12, 24, 36, and 48 months; in neutrophil/lymphocyte ratio ≥5.57 group was 62.4%, 51.3%, 47.8, and 43.7%, respectively (p < 0.0001). Freedom from all amputations was significantly higher in case of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio below the identified cut-off values (p < 0.0001). Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio were found as independent risk factors.

Conclusion

Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are reliable markers for stratification of mortality and limb amputations in patients with acute limb ischaemia. The inexpensive nature and ready availability of these biomarkers' values reinforced their usefulness in everyday clinical practice.

Keywords

Acute limb Ischemia biomarkers amputation peripheral artery disease vascular medicine

Get full access to this article

View all access options for this article.

References

de Donato

Gussoni

de Donato

, et al. The ILAILL study: iloprost ad adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the Italian Society for Vascular and Endovascular Surgery. Ann Surg 2006; 244: 185–193.

The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. Ann Surg 1994; 220: 251–258.

de Donato

Pasqui

Setacci

, et al. Acute on chronic limb ischemia: from surgical embolectomy and thrombolysis to endovascular options. Semin Vasc Surg 2018; 31: 66–75.

Lubrano

Balzan

Consolidated and emerging inflammatory markers in coronary artery disease. World J Exp Med 2015; 5: 21–32.

Stoner

Lucero

Palmer

, et al. Inflammatory biomarkers for predicting cardiovascular disease. Clin Biochem 2013; 46: 1353–1371.

Bhat

Afari

Garcia

LA.

Neutrophil lymphocyte ratio in peripheral vascular disease: a review. Expert Rev Cardiovasc Ther 2016; 14: 871–875.

Bhutta

Agha

Wong

, et al. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross sectional study. Vasc Endovascular Surg 2011; 45: 227–331.

Cetin

Aras

, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology 2016; 67: 336–345.

de Donato

Setacci

Sirignano

, et al. The combination of surgical embolectomy and endovascular techniques may improve outcomes of patients with acute lower limb ischemia. J Vasc Surg 2014; 59: 729–736.

10.

Willerson

Ridker

PM.

Inflammation as a cardiovascular risk factor. Circulation 2004; 109: II2–II10.

11.

Raggi

Genest

Giles

, et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis 2018; 276: 98–108.

12.

Maloberti

Vallerio

Triglione

, et al. Vascular aging and disease of the large vessels: role of inflammation. High Blood Press Cardiovasc Prev 2019; 26: 175–182.

13.

Twig

Afek

Shamiss

, et al. White blood cell count and the risk for coronary artery disease in young adults. PLoS One 2012; 7: e47183.

14.

Chaudhury

Noiret

Higgins

JM.

White blood cell population dynamics for risk stratification of acute coronary syndrome. Proc Natl Acad Sci USA 2017; 114: 12344–12349.

15.

Spark

Sarveswaran

Blest

, et al. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. J Vasc Surg 2010; 52: 632–636.

16.

Furlan

Vergouwen

Fang

, et al. White blood cell count is an independent predictor of outcomes after acute ischaemic stroke. Eur J Neurol 2014; 21: 215–222.

17.

Leclercq

Houard

Philippe

, et al. involvement of intraplaque hemorrage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol 2007; 82: 1420–1429.

18.

Ionita

van den Borne

Catanzariti

, et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Atvb 2010; 30: 1842–1848.

19.

Onsrud

Thorsby

Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. Effect on natural killer cell activity. Scand J Immunol 1981; 13: 573–579.

20.

Hotchkiss

Karl

JE.

The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–150.

21.

Turfan

Erdoğan

Tasal

, et al. Neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with acute heart failure. Clinics (Sao Paulo) 2014; 69: 190–193.

22.

Kang

, et al. Association between blood neutrophil-to-lymphocyte ratio and severity of coronary artery disease: evidence from 17 observational studies involving 7017 cases. Medicine (Baltimore) 2018; 97: e12432.

23.

Park

Seo

Choi

, et al. Importance of predictive value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction. Medicine (Baltimore) 2018; 97: e13471.

24.

Wang

Liu

Sun

, et al. Neutrophil-to-lymphocyte ratio is an effective prognostic indicator for post-amputation patients with critical limb ischemia. Saudi Med J 2017; 38: 24–29.

25.

Kullar

Weerakoddy

Walsh

Neutrophil-lymphocyte ratio predicts graft patency following lower limb revascularisation. Acta Chir Belg 2012; 112: 365–368.

26.

Kurtul

Murat

Yarlioglues

, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol 2014; 114: 972–978.

27.

Cho

Ann

Singh

, et al. Combined usefulness of the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention with a drug-eluting stent. PLoS One 2015; 10: e0133934.

28.

Uzun

Erturk

Cakmak

, et al. Usefulness of the platelet-to-lymphocyte ratio in predicting long-term cardiovascular mortality in patients with the peripheral arterial occlusive disease. Pwki 2017; 13: 32–38.

29.

Taşoğlu

Sert

Colak

, et al. Neutrophil–lymphocyte ratio and the platelet–lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost 2014; 20: 645–650.

30.

Demirdal

Sen

The significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and lymphocyte-monocyte ratio in predicting peripheral arterial disease, peripheral neuropathy, osteomyelitis and amputation in diabetic foot infection. Diabetes Res Clin Pract 2018; 144: 118–125.

31.

de Donato

Gussoni

de Donato

, et al. Acute limb ischemia in elderly patients: can iloprost be useful as an adjuvant to surgery? Results from the ILAILL study. Eur J Vasc Endovasc Surg 2007; 34: 194–198.

32.

de Donato

Pasqui

Giannace

, et al. The Indigo system in acute lower-limb malperfusion (INDIAN) Registry: protocol. JMIR Res Protoc 2019; 8: e9972.

33.

de Donato

Pasqui

Sponza

, et al. Safety and efficacy of vacuum assisted thrombo-aspiration in patients with acute lower limb ischaemia: the INDIAN trial. Eur J Vasc Endovasc Surg 2021; 00047–00042. Feb 26:S1078-5884

34.

Björck

Earnshaw

Acosta

, et al. Editor's choice – European Society for Vascular Surgery (ESVS) 2020 Clinical practice guidelines on the management of acute limb ischaemia. Eur J Vasc Endovasc Surg 2020; 59: 173–218.

35.

Baril

Ghosh

Rosen

AB.

Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population. J Vasc Surg 2014; 60: 669–677.e2.

36.

Taşoğlu

Çiçek

Lafci

, et al. Usefulness of neutrophil/lymphocyte ratio as a predictor of amputation after embolectomy for acute limb ischemia. Ann Vasc Surg 2014; 28: 606–613.